Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoneda

Showing results (61-70 of 454) with videos related to

Pageof 46
Sort By:
Ultrasonography (Seoul, Korea)|January 22, 2026
Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a referenceKento Imajo, Hidenori Toyoda, Satoshi Yasuda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 13, 2010
Clinical classification of congenital extrahepatic portosystemic shuntsNoritoshi Kobayashi, Tetsu Niwa, Hiroyuki Kirikoshi, et al.
Drugs|June 18, 2021
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic AgentsSho Hasegawa, Masato Yoneda, Yusuke Kurita, et al.
Hepatobiliary Surgery and Nutrition|October 27, 2023
Tropifexor, a selective non-acid farnesoid X receptor agonist, improved nonalcoholic steatohepatitis in a phase 2 trial, but several issues remain to be resolvedMasato Yoneda, Takashi Kobayashi, Naohiro Wada, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2016
Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κBMasato Yoneda, Jinhee Hyun, Silvia Jakubski, et al.
Expert Opinion on Pharmacotherapy|November 10, 2018
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adultsYuji Ogawa, Masato Yoneda, Takashi Kobayashi, et al.
Journal of Diabetes Investigation|May 21, 2014
Impact of glucose tolerance on the severity of non-alcoholic steatohepatitisAkinobu Nakamura, Masato Yoneda, Koji Fujita, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Interventional Radiology (Higashimatsuyama-Shi (Japan)|October 10, 2025
Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari SyndromeShingo Koyama, Yuya Koike, Asako Nogami, et al.
Radiology|June 10, 2010
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastographyMasato Yoneda, Kaori Suzuki, Shingo Kato, et al.
Pageof 46

Showing results (61-70 of 454) with videos related to

Sort By:
Pageof 46
Ultrasonography (Seoul, Korea)|January 22, 2026
Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a referenceKento Imajo, Hidenori Toyoda, Satoshi Yasuda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 13, 2010
Clinical classification of congenital extrahepatic portosystemic shuntsNoritoshi Kobayashi, Tetsu Niwa, Hiroyuki Kirikoshi, et al.
Drugs|June 18, 2021
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic AgentsSho Hasegawa, Masato Yoneda, Yusuke Kurita, et al.
Hepatobiliary Surgery and Nutrition|October 27, 2023
Tropifexor, a selective non-acid farnesoid X receptor agonist, improved nonalcoholic steatohepatitis in a phase 2 trial, but several issues remain to be resolvedMasato Yoneda, Takashi Kobayashi, Naohiro Wada, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2016
Hepatitis B Virus and DNA Stimulation Trigger a Rapid Innate Immune Response through NF-κBMasato Yoneda, Jinhee Hyun, Silvia Jakubski, et al.
Expert Opinion on Pharmacotherapy|November 10, 2018
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adultsYuji Ogawa, Masato Yoneda, Takashi Kobayashi, et al.
Journal of Diabetes Investigation|May 21, 2014
Impact of glucose tolerance on the severity of non-alcoholic steatohepatitisAkinobu Nakamura, Masato Yoneda, Koji Fujita, et al.
Expert Opinion on Emerging Drugs|March 12, 2024
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitisMichihiro Iwaki, Masato Yoneda, Naohiro Wada, et al.
Interventional Radiology (Higashimatsuyama-Shi (Japan)|October 10, 2025
Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari SyndromeShingo Koyama, Yuya Koike, Asako Nogami, et al.
Radiology|June 10, 2010
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastographyMasato Yoneda, Kaori Suzuki, Shingo Kato, et al.
Pageof 46